8 weeks versus 12 weeks of sofosbuvir–velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India
{"title":"8 weeks versus 12 weeks of sofosbuvir–velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India","authors":"Amit Goel DM, Sumit Rungta DM, Vinod Kumar DM, Shalimar DM, Ajay Kumar DM, Harshita Katiyar MSc, Surender Singh DM, Amar Deep PhD, Ajay Kumar Mishra DM, Ashish Awasthi PhD, Vikasendu Agarwal MD, Anurag Kumar Tiwari DM, Dawesh Prakash Yadav DM, Sunit Kumar Shukla DM, Ujjwal Sonika DM, Radha Krishan Dhiman DM, Bharat Bhushan Rewari MD, Prof Rakesh Aggarwal DM","doi":"10.1016/s0140-6736(26)01380-2","DOIUrl":null,"url":null,"abstract":"Chronic hepatitis C virus (HCV) infection without cirrhosis can be treated with 12 weeks of sofosbuvir–velpatasvir combination therapy. We aimed to assess whether a shorter 8-week treatment regimen of this combination was non-inferior to the standard 12-week regimen in successfully clearing HCV infection in HCV-infected patients without evidence of cirrhosis.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0140-6736(26)01380-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic hepatitis C virus (HCV) infection without cirrhosis can be treated with 12 weeks of sofosbuvir–velpatasvir combination therapy. We aimed to assess whether a shorter 8-week treatment regimen of this combination was non-inferior to the standard 12-week regimen in successfully clearing HCV infection in HCV-infected patients without evidence of cirrhosis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
